← Back to headlines
FDA Approves Afrezza, Inhaled Insulin for Children and Adolescents with Diabetes
MannKind has announced FDA approval for Afrezza®, the first and only inhaled mealtime insulin specifically for children and adolescents aged 6 and older living with diabetes.
29 May, 16:30 — 29 May, 16:30
